Resources for Food and Drug Administration (FDA)
FDA clears Vesticon Corp.'s medical device for vertigo
www.bizjournals.com The Food and Drug Administration has cleared Vesticon Corp.'s Omniax device to market in the United States. The device is the first ever cleared nationally to assist in the diagnosis and treatment of balance disorders and vertigo, including benign paroxysmal positional vertigo.
Five-year-old Vesticon Corp. developed Omniax and is in talks with several multinational medical device companies for distribution of the product, which will sell for roughly $80,000.
The company has been awarded $4.8 million from the National Institutes of Health Small Business Innovation and Research program, including $2 million to develop Omniax and the remainder to develop two other technologies. Vesticon was Oregon's largest recipient of National Institutes of Health Small Business Innovation and Research grants in 2006 and 2007.
View the Resource
Share or bookmarklet this web page at:
|
RSS Feeds
